Objective To explore the correlation between the epilepsy induced by interleukin-2 (IL-2) and changes of NMDA receptor(NMDAR) and estrogen receptor(ER).
Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.
The reasons were related to emotion, weary, internal damage of food and drink, common cold, constipation, induced abortion, irregular menses and englobement of estrogens.
It is suggested that both Gukang and estrogen can similarly increase BMC and BMD of tuberositas tibiae in ovaricetomized rats,and the changes in BMC and BMD are alike.
As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.
Approved by the FDA in 2001, the patch is sold by prescription and releases ethinyl estradiol (a type of estrogen), and a progestin called norelgestromin via the skin into the bloodstream.